Healthy lifestyle may increase survival for breast cancer survivors
the ONA take:
According to a new study performed by researchers from the American Institute for Cancer Research (AICR) and the World Cancer Research Fund International's Continuous Update Project, a healthy lifestyle that includes exercise, healthy eating, and good weight control may improve survival of patients with breast cancer. For the meta-analysis, researchers analyzed data from over 164,000 women included in 85 studies.
They found that increased survival of patients with breast cancer may be linked with a diet consisting of fiber, soy, and lower saturated fat intake, exercise, and a healthy weight. Despite their findings, the researchers say that their findings do not warrant these recommendations for breast cancer survivors; however, the AICR already recommends that all cancer survivors consume a plant-based diet, exercise, and maintain a healthy weight.
The findings suggest that women who maintain a healthy weight and exercise regularly before and after the diagnosis of their cancer have increased survival rates and a decreased risk for developing a second primary breast cancer. The researchers advise patients to make small changes, such as taking advantage of times to exercise and using pre-chopped or frozen vegetables, to improve their lifestyle.
A healthy lifestyle may improve survival of patients with breast cancer.
Exercise, healthy eating and good weight control may help improve survival of breast cancer patients, according to a large-scale review. Researchers analyzed 85 studies that included more than 164,000 women worldwide and found that breast cancer patient survival may be associated with: a healthy weight, physical activity, eating foods with fiber and soy and lower fat intake, particularly saturated fat.
However, the report from the American Institute for Cancer Research (AICR) and the World Cancer Research FundInternational's Continuous Update Project does say that currently available evidence is still not strong enough to make firm recommendations for breast cancer survivors.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|